Literature DB >> 16426382

Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis.

Aditya K Gupta1, Karyn A Nicol.   

Abstract

Seborrheic dermatitis is a chronic superficial fungal infection of the skin, particularly affecting sites rich in sebaceous glands. Although the precise etiology of seborrheic dermatitis is uncertain, yeasts of the genus Malassezia are known to play a causative role. Ciclopirox is a broad-spectrum, hydroxypyridone-derived, synthetic antifungal agent, which also has anti-inflammatory properties. Ciclopirox is effective both in vitro and in vivo against Malassezia yeasts, making it a valuable option for the treatment of seborrheic dermatitis. Varying frequencies and concentrations of ciclopirox shampoo have been shown to be effective and safe in the treatment of seborrheic dermatitis of the scalp.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16426382     DOI: 10.1111/j.1365-4632.2004.02331.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  5 in total

Review 1.  Topical antifungals for seborrhoeic dermatitis.

Authors:  Enembe O Okokon; Jos H Verbeek; Jani H Ruotsalainen; Olumuyiwa A Ojo; Victor Nyange Bakhoya
Journal:  Cochrane Database Syst Rev       Date:  2015-05-02

Review 2.  Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.

Authors:  Alessandro Subissi; Daniela Monti; Giuseppe Togni; Federico Mailland
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

Review 3.  Commercial Essential Oils as Potential Antimicrobials to Treat Skin Diseases.

Authors:  Ané Orchard; Sandy van Vuuren
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-04       Impact factor: 2.629

4.  Ciclopirox activates PERK-dependent endoplasmic reticulum stress to drive cell death in colorectal cancer.

Authors:  Jianjun Qi; Ningning Zhou; Liyi Li; Shouyong Mo; Yidan Zhou; Yao Deng; Ting Chen; Changliang Shan; Qin Chen; Bin Lu
Journal:  Cell Death Dis       Date:  2020-07-27       Impact factor: 8.469

5.  Cutaneous fungal microbiome: Malassezia yeasts in seborrheic dermatitis scalp in a randomized, comparative and therapeutic trial.

Authors:  C S L Kamamoto; A S Nishikaku; O F Gompertz; A S Melo; K M Hassun; E Bagatin
Journal:  Dermatoendocrinol       Date:  2017-10-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.